Particularly, the EDIM blood test focuses on the detection of two biomarkers, TKTL1 (transketolase-like protein 1) and Apo10 (epitope of DNaseX overexpressed in cancer cells), in CD14+/CD16+ activated monocytes [12]. This evidence concerns the gene TKTL1 and cancer.